Stockreport

AstraZeneca stock jumps 4% after surprise trial win for lung disease drug where rivals have failed [CNBC]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF In this article AstraZeneca 's stock jumped as much as 4% after Britain's most valuable company said its experimental lung disease medicine met its target in two late [Read more]